Physician profile
Leann E Haddock
NPI 1811057359
$4,007.45
in general payments reported to CMS, 2019-2025
42 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $967 · 2020: $1,014 · 2021: $662 · 2022: $841 · 2023: $91.69 · 2024: $242 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $323 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $323.07 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $1,287.74 | 2019-2025 | Dysport |
| Abbvie INC. | $463.14 | 2019-2022 | |
| Merz North America, INC. | $388.25 | 2019-2025 | |
| Pfizer INC. | $239.45 | 2019-2022 | |
| Mimedx Group, INC. | $200.00 | 2024 | |
| Therapeuticsmd, INC. | $181.35 | 2019-2022 | |
| Aspira Women'S Health INC | $110.08 | 2022 | |
| Allergan, INC. | $107.76 | 2019-2022 | |
| Exeltis, USA INC. | $93.43 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $76.78 | 2019-2021 | |
| Hologic Sales and Service, LLC | $56.70 | 2023 | Acessa Provu System, Coolseal Generator, Myosure Tissue Removal Device |
| Amag Pharmaceuticals, INC. | $55.60 | 2019-2020 | |
| Myovant Sciences INC. | $49.29 | 2021-2022 | |
| Medicem INC. | $48.05 | 2020-2021 | |
| Mission Pharmacal Company | $46.45 | 2019-2020 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leann Haddock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.